Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA? https://t.co/Z1xc0UEM62 https://t.co/RK5PY7Jtrc

RT @AmandaButler__: Access to OAT carries is inequitable. OAT guidelines need to support increased access for ppl released from prison, a p…

RT @AmandaButler__: Access to OAT carries is inequitable. OAT guidelines need to support increased access for ppl released from prison, a p…

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA? https://t.co/Z1xc0UnaHs https://t.co/CMNCD4Gwzd